Has Snehal Bhoola, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,366,439 in general payments to Snehal Bhoola, MD across 363 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Snehal Bhoola, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Snehal Bhoola, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Snehal Bhoola, MD

Gynecologic Oncology · Savannah, GANPI 1609821016

Payments from drug & device makers

$1,366,439in general payments, 2019–2025

Across 363 payments — averaging $3764.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Pfizer$1.3M
Tesaro, Inc.$15K
Momentis Surgical Inc.$1K
Intuitive Surgical$725
AstraZeneca$590
GSK$562
plus $6K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Pfizer	71	$1,343,246
Tesaro, Inc.	8	$14,669
Momentis Surgical Inc.	5	$1,013
Intuitive Surgical	10	$725
AstraZeneca(2 entities)	23	$590
GSK	20	$562
Novartis	18	$356
Merck	18	$351
Eisai Inc.	16	$331
Seagen Inc.	10	$324
Johnson & Johnson	13	$314
AbbVie	6	$292
Genmab U.S., Inc.	9	$283
Daiichi Sankyo Inc.	13	$280
Clovis Oncology, Inc.	5	$250
Sanofi	10	$209
Sanofi-aventis U.S. LLC	2	$200
Stryker	1	$139
Baxter Healthcare	4	$138
Bristol Myers Squibb	5	$133
Pharmacyclics LLC, An Abbvie Company	4	$103
Immunogen, Inc.	4	$93
Lilly USA, LLC	4	$90
Bayer	5	$84
Taiho Oncology, Inc.	3	$80
Puma Biotechnology, Inc.	4	$76
Pharmacosmos Therapeutics Inc.	3	$75
Incyte Corporation	4	$73
Karyopharm Therapeutics Inc.	3	$72
Amgen	3	$71
Sobi, Inc	3	$65
Dysis Medical, Inc.	1	$65
Stemline Therapeutics Inc.	3	$65
Genentech USA, Inc.	2	$62
Rigel Pharmaceuticals, Inc.	2	$59
Myovant Sciences Inc.	3	$57
Spectrum Pharmaceuticals Inc.	3	$57
Sumitomo Pharma America, Inc.	2	$48
E.r. Squibb & Sons, L.L.C.	3	$47
Gilead(2 entities)	3	$45
Blueprint Medicines Corporation	2	$39
Takeda Pharmaceuticals U.S.A., Inc.	2	$38
AMAG Pharmaceuticals, Inc.	2	$37
Acrotech Biopharma Inc.	2	$36
Exelixis Inc.	2	$36
Lexicon Pharmaceuticals, Inc.	2	$34
Foundation Medicine, Inc.	1	$31
Ipsen Biopharmaceuticals, Inc	2	$29
Regeneron Healthcare Solutions, Inc.	1	$26
Adaptive Biotechnologies Corporation	1	$25
Jazz Pharmaceuticals Inc.	1	$25
Iovance Biotherapeutics, Inc.	1	$24
Dendreon Pharmaceuticals LLC	1	$23
Integra Lifesciences Corporation	1	$23
Abbott	1	$22
EMD Serono, Inc.	1	$22
Fortovia Therapeutics, Inc.	1	$20
Global Blood Therapeutics, Inc.	1	$19
Tempus AI, Inc	1	$18
BD	1	$17

How this compares

$1,366,439 in reported general payments places this provider in the 95th percentile of 49 gynecologic oncology providers in Georgia.

See all gynecologic oncology providers in Georgia →

Medicare billing

Part B allowed, 2024

$1,200,528

Medicare patients

255

Services billed

51,528

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gynecologic oncology in Savannah

James BurkeSavannah$588K
Sarah GillSavannah$403K
William RichardsSavannah$320
Sharad GhamandeAugusta$8.7M
Benedict BenignoAtlanta$603K
Paul MayorJonesboro$513K
Guilherme CantuariaAtlanta$509K
Meaghan TenneyAtlanta$477K
John WallbillichAugusta$281K
Namita KhannaAtlanta$279K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →